title: Bortezomib-associated cutaneous vasculitis.
authors.forename: X
authors.initials: X
authors.lastname: Garcia-Navarro
authors.forename: L
authors.initials: L
authors.lastname: Puig
authors.forename: M T
authors.initials: MT
authors.lastname: Fernández-Figueras
authors.forename: J
authors.initials: J
authors.lastname: Dalmau
authors.forename: E
authors.initials: E
authors.lastname: Roe
authors.forename: A
authors.initials: A
authors.lastname: Alomar
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D001897:Boronic Acids / Q000009:adverse effects*; D000069286:Bortezomib; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011480:Protease Inhibitors / Q000009:adverse effects; D011719:Pyrazines / Q000009:adverse effects*; D017445:Skin Diseases, Vascular / Q000139:chemically induced*; D014657:Vasculitis / Q000139:chemically induced*
chemical_list: D000970:Antineoplastic Agents; D001897:Boronic Acids; D011480:Protease Inhibitors; D011719:Pyrazines; D000069286:Bortezomib